| Dr Sarah Vondrak Gernhart, MD | |
|
717 N. 190th Plaza Suite 1200, Omaha, NE 68022 | |
| (402) 815-1700 | |
| (402) 815-1955 |
| Full Name | Dr Sarah Vondrak Gernhart |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 717 N. 190th Plaza Suite 1200, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205941069 | NPI | - | NPPES |
| 10026301600 | Medicaid | NE | |
| 47068731799 | Medicaid | NE | |
| 1205941069 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 21299 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Methodist Hospital | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Clinic Inc | 4880506062 | 497 |
News Archive
Minnesota Public Radio: In principal, the new federal healthcare law "requires insurers to cover preventive care — including colonoscopies, mammograms and immunizations at no cost to the patient — no co-pays, no deductibles." The aim is to encourage people to get preventive care before they develop conditions that are more costly to treat, and while "Medicare will begin covering these tests 100 percent on January 1st ... for other plans there are myriad exceptions.
The molecule interleukin-7 is an important immune messenger protein which ensures that a sufficient number of T cells are present in our body for immune defence. Researchers from ETH Zurich have now demonstrated that IL-7 has another important function: it enhances the drainage function of lymphatic vessels, which collect fluid that has leaked out of blood vessels into the body tissue and return it to the bloodstream.
Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.
Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop venous thromboembolism (VTE), a dangerous, often life-threatening condition, according to study results published today in Blood, the Journal of the American Society of Hematology.
› Verified 1 days ago
| Entity Name | Physicians Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821049156 PECOS PAC ID: 4880506062 Enrollment ID: O20031105000345 |
News Archive
Minnesota Public Radio: In principal, the new federal healthcare law "requires insurers to cover preventive care — including colonoscopies, mammograms and immunizations at no cost to the patient — no co-pays, no deductibles." The aim is to encourage people to get preventive care before they develop conditions that are more costly to treat, and while "Medicare will begin covering these tests 100 percent on January 1st ... for other plans there are myriad exceptions.
The molecule interleukin-7 is an important immune messenger protein which ensures that a sufficient number of T cells are present in our body for immune defence. Researchers from ETH Zurich have now demonstrated that IL-7 has another important function: it enhances the drainage function of lymphatic vessels, which collect fluid that has leaked out of blood vessels into the body tissue and return it to the bloodstream.
Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.
Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop venous thromboembolism (VTE), a dangerous, often life-threatening condition, according to study results published today in Blood, the Journal of the American Society of Hematology.
› Verified 1 days ago
| Entity Name | Nebraska Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689628372 PECOS PAC ID: 6901707447 Enrollment ID: O20040116000781 |
News Archive
Minnesota Public Radio: In principal, the new federal healthcare law "requires insurers to cover preventive care — including colonoscopies, mammograms and immunizations at no cost to the patient — no co-pays, no deductibles." The aim is to encourage people to get preventive care before they develop conditions that are more costly to treat, and while "Medicare will begin covering these tests 100 percent on January 1st ... for other plans there are myriad exceptions.
The molecule interleukin-7 is an important immune messenger protein which ensures that a sufficient number of T cells are present in our body for immune defence. Researchers from ETH Zurich have now demonstrated that IL-7 has another important function: it enhances the drainage function of lymphatic vessels, which collect fluid that has leaked out of blood vessels into the body tissue and return it to the bloodstream.
Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.
Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop venous thromboembolism (VTE), a dangerous, often life-threatening condition, according to study results published today in Blood, the Journal of the American Society of Hematology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sarah Vondrak Gernhart, MD 717 N. 190th Plaza Suite 1200, Omaha, NE 68022 Ph: (402) 815-1700 | Dr Sarah Vondrak Gernhart, MD 717 N. 190th Plaza Suite 1200, Omaha, NE 68022 Ph: (402) 815-1700 |
News Archive
Minnesota Public Radio: In principal, the new federal healthcare law "requires insurers to cover preventive care — including colonoscopies, mammograms and immunizations at no cost to the patient — no co-pays, no deductibles." The aim is to encourage people to get preventive care before they develop conditions that are more costly to treat, and while "Medicare will begin covering these tests 100 percent on January 1st ... for other plans there are myriad exceptions.
The molecule interleukin-7 is an important immune messenger protein which ensures that a sufficient number of T cells are present in our body for immune defence. Researchers from ETH Zurich have now demonstrated that IL-7 has another important function: it enhances the drainage function of lymphatic vessels, which collect fluid that has leaked out of blood vessels into the body tissue and return it to the bloodstream.
Immune responses to prevent or delay the spread of melanoma, a deadly form of skin cancer, are more likely to prolong survival in patients if their immune cells carry a special kind of marker on the surface, according to a team of researchers at the University of Virginia Health System.
Patients with clinically diagnosed superficial vein thrombosis (SVT), a blood clot in the veins just beneath the skin that commonly resolves on its own without treatment, are four to six times more likely to develop venous thromboembolism (VTE), a dangerous, often life-threatening condition, according to study results published today in Blood, the Journal of the American Society of Hematology.
› Verified 1 days ago
Dr. Elizabeth Stephens Constance, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 7308 S 142nd St, Omaha, NE 68138 Phone: 402-717-4200 | |
Jennifer Marie Burgart, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7710 Mercy Rd Ste 202, Omaha, NE 68124 Phone: 402-280-4438 | |
Dr. Grace Binter, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 983255 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-6160 | |
Dr. Stephanie Lynn Fisher Gustin, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7308 S 142nd St, Omaha, NE 68138 Phone: 402-717-4200 Fax: 402-717-4231 | |
Dr. Alex Keith Laudenklos, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Cu Department Of Obstetrics And Gynecology, Omaha, NE 68131 Phone: 402-717-0947 | |
Mr. Kent Harry Siemers, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7205 W Center Rd, Suite 200, Omaha, NE 68124 Phone: 402-397-6600 Fax: 402-397-8318 | |
Dr. Brent Jonathan Tierney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Suite 300, Omaha, NE 68114 Phone: 402-354-5250 Fax: 402-354-3437 |